Filters
Blog Options
appstore google_play
Close

Predniderm 120 gm - Vetoquinol

Manufacturer: Vetoquinol - France
Predniderm 120 gm - Vetoquinol
Vendor: BioVet
120.00 QAR
Availability: 4 in stock
- +

1. Name of the veterinary medicinal product

PREDNIDERM


2. Qualitative and quantitative composition

One g contains:

Active substance(s):
Neomycin ....................(as sulfate) 3333.33 IU
Prednisolone ....................(as acetate) 1.34 mg

Excipient(s):
Phenylmercury nitrate .............. 0.05 mg


For the full list of excipients, see section “List of excipients”.


3. Pharmaceutical form

Emulsion for cutaneous application.


4. Clinical particulars

4.1. Target species

Equines, dogs and cats.


4.2. Indications for use, specifying the target species

In equines, dogs and cats:
- Treatment of skin conditions caused by germs sensitive to neomycin.


4.3. Contraindications

Hypersensitivity to any of the constituents, in particular to neomycin.


4.4. Special warnings for each target species

None.


4.5. Special precautions for use

i) Special precautions for use in animals

Inappropriate use of the product may increase the prevalence of bacteria resistant to neomycin.
Avoid licking the animal immediately after application of the product.


ii) Special precautions to be taken by the person administering the veterinary medicinal product to animals

It is recommended that persons administering the veterinary medicinal product to animals wear gloves.
In case of splashing in the eyes, rinse thoroughly with water.
In case of accidental ingestion, seek medical advice and show the package leaflet or the label to the physician.
People with known hypersensitivity to any of the ingredients should avoid contact with the product.


iii) Other precautions

None.


4.6. Adverse reactions (frequency and seriousness)

With prolonged use, corticosteroids such as prednisolone may cause iatrogenic hypercorticism, polyuropolydipsia (PUPD), immunosuppression, bulimia and redistribution of body fat reserves.


4.7. Use during pregnancy, lactation or lay

Studies in laboratory animals have shown embryotoxic effects of prednisolone.
Administration of corticosteroids during pregnancy is not recommended.


4.8. Drug interactions and other forms of interaction

In case of prolonged use, do not combine with non-steroidal anti-inflammatory drugs (NSAIDs).


4.9. Dosage and route of administration

External use.

Apply a small amount of emulsion to the lesions, two to three times a day depending on the severity of the case.
Repeat these applications:
- Every day for the initial treatment.
- 2 to 3 times a week for the maintenance treatment.
A gentle massage facilitates the penetration of the active ingredients. The use of gloves is recommended.
Shake well before use.


4.10. Overdose (symptoms, emergency procedures, antidotes), if necessary

In case of prolonged use, usual effects known to corticosteroids, see section "Adverse reactions".


4.11. Withdrawal period

Equines:
Meat and offal: zero days.
Milk: in the absence of MRLs for milk, do not use in females producing drinking milk, in lactation or in the dry period or in future females producing drinking milk in the 2 months preceding parturition.


5. Pharmacological properties

Pharmacotherapeutic group: local combination of a corticosteroid and an aminoglycoside antibiotic.

5.1. Pharmacodynamic properties

Neomycin is an aminoglycoside antibiotic, obtained from Streptomyces fradiae. Its spectrum of activity covers Gram-positive germs, particularly Staphylococci and less actively Streptococci, and Gram-negative germs, particularly Escherichia coli. Neomycin
binds to the 30S subunit of the bacterial ribosome, disrupting the reading of the constitutive code of messenger RNA, and ultimately bacterial protein synthesis. At high concentrations, aminoglycosides have been shown to damage the bacterial cell wall, adding bactericidal properties to the bacteriostatic properties.

Prednisolone is a synthetic steroidal anti-inflammatory drug belonging to the glucocorticoid family. It is used for its anti-inflammatory, immunosuppressive and antiallergic properties.


5.2. Pharmacokinetic characteristics

No data available.


6. Pharmaceutical particulars

6.1. List of excipients

Phenylmercury nitrate
Tristearin
Polysorbate 80
Macrogol stearate 300
Perfume 48 536
Liquid paraffin
Purified water

1. Name of the veterinary medicinal product

PREDNIDERM


2. Qualitative and quantitative composition

One g contains:

Active substance(s):
Neomycin ....................(as sulfate) 3333.33 IU
Prednisolone ....................(as acetate) 1.34 mg

Excipient(s):
Phenylmercury nitrate .............. 0.05 mg


For the full list of excipients, see section “List of excipients”.


3. Pharmaceutical form

Emulsion for cutaneous application.


4. Clinical particulars

4.1. Target species

Equines, dogs and cats.


4.2. Indications for use, specifying the target species

In equines, dogs and cats:
- Treatment of skin conditions caused by germs sensitive to neomycin.


4.3. Contraindications

Hypersensitivity to any of the constituents, in particular to neomycin.


4.4. Special warnings for each target species

None.


4.5. Special precautions for use

i) Special precautions for use in animals

Inappropriate use of the product may increase the prevalence of bacteria resistant to neomycin.
Avoid licking the animal immediately after application of the product.


ii) Special precautions to be taken by the person administering the veterinary medicinal product to animals

It is recommended that persons administering the veterinary medicinal product to animals wear gloves.
In case of splashing in the eyes, rinse thoroughly with water.
In case of accidental ingestion, seek medical advice and show the package leaflet or the label to the physician.
People with known hypersensitivity to any of the ingredients should avoid contact with the product.


iii) Other precautions

None.


4.6. Adverse reactions (frequency and seriousness)

With prolonged use, corticosteroids such as prednisolone may cause iatrogenic hypercorticism, polyuropolydipsia (PUPD), immunosuppression, bulimia and redistribution of body fat reserves.


4.7. Use during pregnancy, lactation or lay

Studies in laboratory animals have shown embryotoxic effects of prednisolone.
Administration of corticosteroids during pregnancy is not recommended.


4.8. Drug interactions and other forms of interaction

In case of prolonged use, do not combine with non-steroidal anti-inflammatory drugs (NSAIDs).


4.9. Dosage and route of administration

External use.

Apply a small amount of emulsion to the lesions, two to three times a day depending on the severity of the case.
Repeat these applications:
- Every day for the initial treatment.
- 2 to 3 times a week for the maintenance treatment.
A gentle massage facilitates the penetration of the active ingredients. The use of gloves is recommended.
Shake well before use.


4.10. Overdose (symptoms, emergency procedures, antidotes), if necessary

In case of prolonged use, usual effects known to corticosteroids, see section "Adverse reactions".


4.11. Withdrawal period

Equines:
Meat and offal: zero days.
Milk: in the absence of MRLs for milk, do not use in females producing drinking milk, in lactation or in the dry period or in future females producing drinking milk in the 2 months preceding parturition.


5. Pharmacological properties

Pharmacotherapeutic group: local combination of a corticosteroid and an aminoglycoside antibiotic.

5.1. Pharmacodynamic properties

Neomycin is an aminoglycoside antibiotic, obtained from Streptomyces fradiae. Its spectrum of activity covers Gram-positive germs, particularly Staphylococci and less actively Streptococci, and Gram-negative germs, particularly Escherichia coli. Neomycin
binds to the 30S subunit of the bacterial ribosome, disrupting the reading of the constitutive code of messenger RNA, and ultimately bacterial protein synthesis. At high concentrations, aminoglycosides have been shown to damage the bacterial cell wall, adding bactericidal properties to the bacteriostatic properties.

Prednisolone is a synthetic steroidal anti-inflammatory drug belonging to the glucocorticoid family. It is used for its anti-inflammatory, immunosuppressive and antiallergic properties.


5.2. Pharmacokinetic characteristics

No data available.


6. Pharmaceutical particulars

6.1. List of excipients

Phenylmercury nitrate
Tristearin
Polysorbate 80
Macrogol stearate 300
Perfume 48 536
Liquid paraffin
Purified water

Write your own review
  • Only registered users can write reviews
*
*
  • Bad
  • Excellent
*
*
*
Product tags